02/14/2025
11:37 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/15/2025
3:14 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
3:27 PM | Dellora Investments LP (Reporting)
Tenax Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/12/2024
7:02 PM | Giordano Christopher Thomas (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:04 PM | Hunter Robyn (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:07 PM | PROEHL GERALD T (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
7:09 PM | Rich Stuart (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:49 PM | Almenoff June Sherie (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:54 PM | Davidson Michael H. (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:58 PM | Doogan Declan (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:54 PM | MCGAULEY THOMAS (Reporting)
Tenax Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for TENX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/05/2024
12:47 PM | Dellora Investments LP (Filed by)
Tenax Therapeutics (Subject)
| Form SCHEDULE 13G | |
11/26/2024
3:30 PM | Tenax Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/14/2024
6:14 PM | Lind Global Fund II LP (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
11:39 AM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
11:21 AM | CVI Investments, Inc. (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
4:35 PM | Stonepine Capital Management, LLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
7:15 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
10/30/2024
3:32 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
7:14 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
09/12/2024
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
09/12/2024
3:15 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
09/10/2024
4:19 PM | PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/30/2024
3:19 PM | Tenax Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/30/2024
3:20 PM | Tenax Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/23/2024
3:31 PM | Tenax Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
08/19/2024
5:48 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/15/2024
3:19 PM | Stonepine Capital Management, LLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/14/2024
5:47 PM | Tenax Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
08/14/2024
2:19 PM | JANUS HENDERSON GROUP PLC (Filed by)
Tenax Therapeutics (Subject)
| Form SC 13G | |
08/13/2024
3:45 PM | Tenax Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:35 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:42 PM | Davidson Michael H. (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:43 PM | PROEHL GERALD T (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
6:23 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
3:32 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
4:00 PM | Giordano Christopher Thomas (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:01 PM | Rich Stuart (Reporting)
Tenax Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:01 PM | Tenax Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
8:01 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Collect $7k per month from Tesla’s SECRET dividend (Ad) There's a little-known secret about Tesla that even seasoned investors don't know.
Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month.
This backdoor strategy is changing the game for smart investors.
Want to see how it works? Click here to uncover Tesla's hidden income secret. |
04/26/2024
7:42 AM | Tenax Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
7:50 AM | Tenax Therapeutics (Filer)
| Form ARS | |
04/26/2024
7:30 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
7:30 AM | Tenax Therapeutics (Filer)
| Form DEF 14A | |
04/14/2024
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
04/14/2024
11:15 PM | Tenax Therapeutics (Filer)
| Form EFFECT | |
04/11/2024
3:56 PM | Tenax Therapeutics (Filer)
| Form POS AM | |
04/11/2024
3:59 PM | Tenax Therapeutics (Filer)
| Form POS AM | |
03/28/2024
1:02 PM | Tenax Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
7:45 AM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
3:31 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/26/2024
3:31 PM | Tenax Therapeutics (Filer)
| Form 424B3 | |
02/23/2024
3:30 PM | Tenax Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
